Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors

Cancer diagnostics and therapies have improved steadily over the last few decades, markedly increasing life expectancy for patients at all ages. However, conventional and newer anti-neoplastic therapies can cause short- and long-term cardiotoxicity. The clinical implications of this cardiotoxicity b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Neha, Adams, M. Jacob, Ganatra, Sarju, Colan, Steven D., Aggarwal, Sanjeev, Steiner, Rudolf, Amdani, Shahnawaz, Lipshultz, Emma R., Lipshultz, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048046/
https://www.ncbi.nlm.nih.gov/pubmed/32154024
http://dx.doi.org/10.1186/s40959-019-0054-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048046/
https://www.ncbi.nlm.nih.gov/pubmed/32154024
http://dx.doi.org/10.1186/s40959-019-0054-5

Ejemplares similares